L-Thyroxine intake as a potential risk factor for the development of fatigue in breast cancer patients undergoing chemotherapy

Martina E. Schmidt, Joachim Wiskemann, Theron Johnson, Nina Habermann, Andreas Schneeweiss, Karen Steindorf

Open source

DOI
10.1007/s00520-018-4095-3
Published
2018-02-14
Container
Supportive Care in Cancer
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00520-018-4095-3,
  title = {L-Thyroxine intake as a potential risk factor for the development of fatigue in breast cancer patients undergoing chemotherapy},
  author = {Martina E. Schmidt and Joachim Wiskemann and Theron Johnson and Nina Habermann and Andreas Schneeweiss and Karen Steindorf},
  year = {2018},
  journal = {Supportive Care in Cancer},
  doi = {10.1007/s00520-018-4095-3},
  url = {https://doi.org/10.1007/s00520-018-4095-3}
}

RIS

TY  - JOUR
TI  - L-Thyroxine intake as a potential risk factor for the development of fatigue in breast cancer patients undergoing chemotherapy
AU  - Martina E. Schmidt
AU  - Joachim Wiskemann
AU  - Theron Johnson
AU  - Nina Habermann
AU  - Andreas Schneeweiss
AU  - Karen Steindorf
PY  - 2018
JO  - Supportive Care in Cancer
DO  - 10.1007/s00520-018-4095-3
UR  - https://doi.org/10.1007/s00520-018-4095-3
ER  - 

APA

Schmidt, M. E., Wiskemann, J., Johnson, T., Habermann, N., Schneeweiss, A., & Steindorf, K. (2018). L-Thyroxine intake as a potential risk factor for the development of fatigue in breast cancer patients undergoing chemotherapy. Supportive Care in Cancer. https://doi.org/10.1007/s00520-018-4095-3

Source records